Annuncio pubblicitario
Italia markets closed

  • FTSE MIB

    34.249,77
    +310,02 (+0,91%)
     

  • Dow Jones

    38.239,66
    +153,86 (+0,40%)
     

  • Nasdaq

    15.927,90
    +316,14 (+2,03%)
     

  • Nikkei 225

    37.934,76
    +306,28 (+0,81%)
     

  • Petrolio

    83,66
    +0,09 (+0,11%)
     

  • Bitcoin EUR

    59.824,90
    -775,78 (-1,28%)
     

  • CMC Crypto 200

    1.333,87
    -62,66 (-4,49%)
     

  • Oro

    2.349,70
    +7,20 (+0,31%)
     

  • EUR/USD

    1,0694
    -0,0039 (-0,36%)
     

  • S&P 500

    5.099,96
    +51,54 (+1,02%)
     

  • HANG SENG

    17.651,15
    +366,61 (+2,12%)
     

  • Euro Stoxx 50

    5.006,85
    +67,84 (+1,37%)
     

  • EUR/GBP

    0,8558
    -0,0015 (-0,18%)
     

  • EUR/CHF

    0,9778
    -0,0007 (-0,07%)
     

  • EUR/CAD

    1,4612
    -0,0037 (-0,25%)
     

CooperCompanies to Participate in the Wells Fargo Healthcare Conference

CooperCompanies
·1 minuto per la lettura
CooperCompanies
CooperCompanies

SAN RAMON, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:20 PM ET.

A live webcast of the Company’s session can be accessed from Cooper’s investor relations website at http://investor.coopercos.com. A replay will be available on the same web page following the event.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com